BOL production capacity is bigger than all the other 7 LPs in Israel combined.

BOL is the only company in Israel who is accredited throughout  all value chain according to the new regulations that allow selling in pharmacies and for export.

Specializes in cultivation of raw material and development and production of APIs and finished products, including 3rd party drug development.

As one of the few companies globally capable of providing commercial quantities of CBD pharma-grade APIs and finished  products, BOL will address a bottleneck of 400+ clinical trials that are on hold due to insufficient production of cannabis based APIs.

Font Resize